Literature DB >> 28757618

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

A M Zeidan1, M A Sekeres2, J Barnard2, D P Steensma3, R Komrokji4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28757618     DOI： 10.1038/leu.2017.238

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Therapy-related myelodysplastic syndromes, or are they?

Authors:  Abdallah Abou Zahr; Ami M Kavi; Sudipto Mukherjee; Amer M Zeidan
Journal:  Blood Rev       Date:  2016-11-24       Impact factor: 8.250

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.

Authors:  Zeba N Singh; Dezheng Huo; John Anastasi; Sonali M Smith; Theodore Karrison; Michelle M Le Beau; Richard A Larson; James W Vardiman
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

4.  Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS).

Authors:  Luca Malcovati; Matteo G Della Porta; Corinna Strupp; Ilaria Ambaglio; Andrea Kuendgen; Kathrin Nachtkamp; Erica Travaglino; Rosangela Invernizzi; Cristiana Pascutto; Mario Lazzarino; Ulrich Germing; Mario Cazzola
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

5.  Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

Authors:  Antonio C Wolff; Amanda L Blackford; Kala Visvanathan; Hope S Rugo; Beverly Moy; Lori J Goldstein; Keith Stockerl-Goldstein; Leigh Neumayer; Terry S Langbaum; Richard L Theriault; Melissa E Hughes; Jane C Weeks; Judith E Karp
Journal:  J Clin Oncol       Date:  2014-12-22       Impact factor: 44.544

6.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

Authors:  Tetsuichi Yoshizato; Yasuhito Nannya; Yoshiko Atsuta; Yusuke Shiozawa; Yuka Iijima-Yamashita; Kenichi Yoshida; Yuichi Shiraishi; Hiromichi Suzuki; Yasunobu Nagata; Yusuke Sato; Nobuyuki Kakiuchi; Keitaro Matsuo; Makoto Onizuka; Keisuke Kataoka; Kenichi Chiba; Hiroko Tanaka; Hiroo Ueno; Masahiro M Nakagawa; Bartlomiej Przychodzen; Claudia Haferlach; Wolfgang Kern; Kosuke Aoki; Hidehiro Itonaga; Yoshinobu Kanda; Mikkael A Sekeres; Jaroslaw P Maciejewski; Torsten Haferlach; Yasushi Miyazaki; Keizo Horibe; Masashi Sanada; Satoru Miyano; Hideki Makishima; Seishi Ogawa
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

Review 7.  Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?

Authors:  Aziz Nazha; Mikkael A Sekeres; Steven D Gore; Amer M Zeidan
Journal:  Oncologist       Date:  2015-07-20

8.  Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

Authors:  Hagop Kantarjian; Susan O'Brien; Farhad Ravandi; Jorge Cortes; Jianqin Shan; John M Bennett; Alan List; Pierre Fenaux; Guillermo Sanz; Jean-Pierre Issa; Emil J Freireich; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

9.  A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Authors:  Alfonso Quintás-Cardama; Naval Daver; Hawk Kim; Courtney Dinardo; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Sherry Pierce; Jianqin Shan; Marylou Cardenas-Turanzas; Jorge Cortes; Farhad Ravandi; William Wierda; Zeev Estrov; Stefan Faderl; Yue Wei; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-05-06

10.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Authors:  Valentina Nardi; Karen M Winkfield; Chi Young Ok; Andrzej Niemierko; Michael J Kluk; Eyal C Attar; Guillermo Garcia-Manero; Sa A Wang; Robert P Hasserjian
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.